Test Price
2,800 AED✅ Home Collection Available
ACTN4 Gene (FSGS Type 1) Next-Generation Sequencing Genetic Test in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary telephonic post-test clinical guidance by a DHA-certified Consultant Medical Genetics.
- Insurance Support: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The ACTN4 gene test identifies pathogenic variants linked to autosomal dominant focal segmental glomerulosclerosis type 1 (FSGS1), a progressive kidney disorder. This next-generation sequencing (NGS) assay provides comprehensive coverage of the entire coding region and splice sites, enabling precise genetic diagnosis to guide renal surveillance and early treatment decisions.
| Feature | Our Test (ACTN4 NGS) | Closest Alternative (Traditional Sanger / Overseas Lab) |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) – comprehensive coverage of entire coding region & splice sites | Sanger sequencing (single-gene), often incomplete coverage |
| Turnaround Time | 3–4 weeks | 6–8 weeks (international shipping delays) |
| Price | 2,800 AED | 3,500+ AED (incl. courier) |
| Regulatory Compliance | DHA/MOHAP, ISO 9001:2015, UAE PDPL | Often lacks local data privacy compliance |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) emphasizes: “A positive ACTN4 mutation indicates an elevated lifelong risk for FSGS, but disease penetrance is incomplete; surveillance with urinalysis and eGFR remains essential. Clinical correlation and family counselling are paramount before any intervention. Genetic results are a piece of the puzzle, not a definitive forecast.”
Critical Medication Advisory
Do not discontinue or adjust any prescribed medication (including antihypertensives, immunosuppresants, or steroids) without consulting your treating physician. Genetic results alone do not constitute a treatment directive.
Exclusion Criteria & Emergency Red Flags
Sample Collection Denied:
- Active severe infection requiring systemic therapy.
- Known severe bleeding disorder (e.g., haemophilia A with factor level <1%) without haematology clearance.
- Inability to provide informed consent (cognitive impairment and no legal guardian present).
Emergency Red Flags – Seek Immediate Care:
- Sudden onset flank pain with hematuria (possible renal vein thrombosis).
- Rapidly progressing leg/eyelid swelling (anasarca) or oliguria (<200 mL urine/24h).
- Severe hypertension (>180/120 mmHg) with visual disturbances.
Patient FAQ & Clinical Guidance
1. What does a positive ACTN4 mutation mean for my kidney health?
Snippet: A positive ACTN4 variant confirms a genetic predisposition to focal segmental glomerulosclerosis type 1, requiring lifelong renal monitoring but not necessarily disease onset.
Clinical follow-up includes annual urinalysis, eGFR measurement, and blood pressure control; your nephrologist will interpret the result in the context of your personal and family history.
2. Is this genetic test covered by UAE health insurance?
Snippet: Many UAE insurers partially cover genetic testing for symptomatic individuals with a strong family history; pre-authorization and direct billing verification are facilitated via WhatsApp.
Provide your insurance card copy to +971 54 548 8731 and our team will confirm coverage within 2 working hours. Self-pay packages are also available.
3. How is the sample collected and is it safe for children?
Snippet: The test requires 3–5 mL of venous blood drawn under standard sterile procedure; it is safe for minors with parental consent under UAE genetic testing regulations.
We provide certified home collection with temperature-controlled chain, and paediatric blood draws are performed using fine needles with a paediatric specialist present.
UAE Regulatory & Data Privacy Adherence
This test is performed under the regulatory oversight of the Dubai Health Authority (DHA) and complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for all patient data handling. Health information is processed in accordance with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory holds ISO 9001:2015 certification.
Clinical & Logistical Metadata
| Test Name | ACTN4 Gene (FSGS Type 1) Next-Generation Sequencing Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA) |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | N04.1, Z15.09 |
| LOINC Code | 21613-5 |
| DHA Facility License & Address | DHA License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians